Skip To Main Content
Barbara Sicalides on Muck Rack

Barbara Sicalides

As seen in: Reuters, Law360, American Bar Association, JD Supra, Lexology, Mondaq, Westlaw Today, LexBlog, Concurrences, Law360 UK and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara

Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A Cautionary Tale: FTC Obtains $12M Settlement for HSR Act Failure to File Violation

|
By Barbara Sicalides, Daniel Anziska, Julian Newton Weiss
| Troutman Pepper Podcasts
This article was originally published on American Bar Association and is republished here with permission as it originally appeared on August 6, 2026. The Federal Trade Commission imposed $12 million in penalties against Edwards Lifesciences Corp. and Genesis MedTech Group Ltd. for closing a July 2024 acquisition without required Hart-Scott-Rodino Act premerger notification.
Open in Who Shared Issue with article?

A Cautionary Tale: FTC Obtains $12M Settlement for HSR Act Failure to File Violation

|
By Barbara Sicalides, Daniel Anziska, Julian Newton Weiss
| American Bar Association Verified
Summary The Federal Trade Commission imposed $12 million in penalties against Edwards Lifesciences Corp. and Genesis MedTech Group Ltd. for closing a July 2024 acquisition without required Hart-Scott-Rodino Act premerger notification. The FTC alleged the parties intentionally structured the deal—including a contemporaneous $25 million purchase of nonvoting securities—to keep the voting securities valuation below the $119.5 million HSR threshold.
Open in Who Shared Issue with article?

A Cautionary Tale: FTC Obtains $12M Settlement for HSR Act Failure to File Violation

|
By Barbara Sicalides
| ABA Business Law Section Verified
The Federal Trade Commission (“FTC”) announced on July 13, 2026, that it imposed penalties, totaling $12 million, in a failure-to-file settlement with Edwards Lifesciences Corp. (“Edwards”) and Genesis MedTech Group Limited (“Genesis MedTech”). The FTC complaint alleges that the companies violated the Hart-Scott-Rodino Act (“HSR Act”) when they closed an acquisition in July 2024 without submission of the required premerger notification and observation of the required waiting period.
Open in Who Shared Issue with article?
See all 176 articles